The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Every-other-day or once-a-week: Long-term efficacy outcomes of the multicenter randomised PATRIOT prostate SBRT trial.
 
Wee Loon Ong
No Relationships to Disclose
 
Harvey Charles Quon
No Relationships to Disclose
 
Aldrich Ong
No Relationships to Disclose
 
Patrick Cheung
No Relationships to Disclose
 
William Chu
No Relationships to Disclose
 
Hans T. Chung
Honoraria - Tersera Canada Inc.; Tolmar Pharmaceuticals Canada Inc.
Travel, Accommodations, Expenses - Tolmar Pharmaceuticals Canada Inc.
 
Danny Vesprini
Honoraria - Elekta; Merck
Consulting or Advisory Role - AstraZeneca Canada
 
Amit Chowdhury
No Relationships to Disclose
 
Dilip Panjwani
No Relationships to Disclose
 
Yasir Alayed
No Relationships to Disclose
 
Geordi Pang
No Relationships to Disclose
 
Renee Korol
No Relationships to Disclose
 
Melanie Davidson
No Relationships to Disclose
 
Ananth Ravi
No Relationships to Disclose
 
Boyd McCurdy
No Relationships to Disclose
 
Liying Zhang
No Relationships to Disclose
 
Meghan Kulasingham-Poon
No Relationships to Disclose
 
Alexandre Mamedov
No Relationships to Disclose
 
Andrea Deabreu
No Relationships to Disclose
 
Andrew Loblaw
Employment - Sanofi (I)
Stock and Other Ownership Interests - Sanofi (I)
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Knight Therapeutics; Tersera; Tolmar
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Sanofi; TerSera
Research Funding - Tersera
Patents, Royalties, Other Intellectual Property - Prostate immobilization device (GU-Lok)